Introduction: When to Seek Diagnostic Evaluation

If you or someone you know begins showing unusual changes in movement, speech, or responsiveness, it may be time to seek medical attention. Catatonia, a disorder that disrupts how the brain manages movement and awareness, can appear suddenly and requires prompt recognition. People with catatonia may become very still and unresponsive, or conversely, they may show excessive, purposeless movement and agitation.^[1]

Anyone experiencing sudden changes such as not speaking, not moving, holding unusual body positions, or repeating movements without clear purpose should be evaluated by a doctor experienced in recognizing this condition. Family members often notice these changes first, as the person may stop responding to their environment or begin acting in ways that seem out of character. Catatonia can happen to anyone, regardless of age, race, or gender, though it is more commonly seen in people with certain mental health conditions like bipolar disorder, depression, or schizophrenia.^[3]

Early diagnosis is particularly important because catatonia can become a medical emergency if left untreated. When severe, it can affect a person’s ability to eat, drink, or regulate body temperature, breathing, and heart rate—a dangerous form sometimes called malignant catatonia. This life-threatening presentation requires immediate medical intervention.^[3] Even in less severe cases, catatonia can be distressing and interfere significantly with daily functioning, making timely diagnosis essential for starting appropriate treatment.

Studies show that catatonia occurs in approximately 10% of people who need inpatient psychiatric care, yet it remains widely underdiagnosed. Many healthcare providers may not recognize it because its symptoms can overlap with other conditions, or because they mistakenly believe it only occurs in people with schizophrenia. In reality, catatonia can develop secondary to various psychiatric disorders, neurological conditions, and general medical illnesses.^[2]

Classic Diagnostic Methods

Diagnosing catatonia requires a thorough clinical evaluation by a medical doctor with experience in recognizing this syndrome. Unlike many medical conditions that can be confirmed with a blood test or scan, catatonia is identified primarily through careful observation and physical examination. The doctor will look for specific signs and symptoms that indicate the presence of this motor disorder.^[3]

Clinical Examination and Observation

The diagnostic process begins with observing how the person moves, responds, and interacts with their environment. Because people with catatonia often cannot provide a reliable history of their symptoms, information from family members or caregivers becomes crucial. Doctors will ask about when the unusual behaviors started, whether there were any triggering events, and if the person has a history of psychiatric or medical conditions.^[6]

During the physical examination, the doctor looks for characteristic signs of catatonia. These include observing whether the person responds to questions or commands, how they move or hold their body, and whether they show any repetitive or unusual behaviors. The examination is not painful but may involve the doctor gently moving the person’s limbs to check for specific features like waxy flexibility, where the person’s limbs can be positioned by the examiner and will remain in that position.^[2]

Diagnostic Criteria and Rating Scales

According to the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), there are twelve officially recognized symptoms of catatonia. These include behaviors such as not speaking (mutism), not moving (stupor), holding positions when placed by others (catalepsy), copying others’ words (echolalia) or movements (echopraxia), showing purposeless agitation, grimacing, and displaying repetitive movements without clear purpose (stereotypy). At least three of these symptoms must be present to make a diagnosis of catatonia.^[1][2]

To help standardize the diagnostic process, doctors often use specialized rating scales. The Bush-Francis Catatonia Rating Scale is one of the most widely used tools for both screening and measuring the severity of catatonia symptoms. This scale guides clinicians through a structured examination, checking for various signs including automatic obedience (following all commands even if harmful), autonomic abnormalities (changes in vital signs), and the presence of a grasp reflex. Using such scales helps ensure that doctors don’t miss subtle signs and can track how symptoms change over time.^[3][10]

Distinguishing Catatonia from Other Conditions

One of the biggest challenges in diagnosing catatonia is distinguishing it from other conditions with similar features. Catatonia can look similar to delirium, a state of confusion and altered consciousness, but these are fundamentally different conditions. Delirium primarily involves problems with attention and awareness and reflects dysfunction of the brain’s outer layer (cortex), while catatonia is mainly a disorder of movement regulation involving deeper brain structures called the basal ganglia.^[7]

Other conditions that may mimic catatonia include neuroleptic malignant syndrome (a dangerous reaction to antipsychotic medications), certain types of brain inflammation (encephalitis), seizures that don’t cause obvious convulsions (nonconvulsive status epilepticus), and severe psychosis. Each of these conditions requires different treatment, making accurate diagnosis critical. Doctors must carefully rule out these other possibilities through additional tests and examinations.^[6]

The Lorazepam Challenge Test

One unique diagnostic tool for catatonia is called the lorazepam challenge or benzodiazepine challenge test. This involves giving the patient a dose of lorazepam, a medication from the benzodiazepine family, and then observing whether catatonic symptoms improve. If the person shows significant improvement in movement, speech, or responsiveness within one to two hours after receiving lorazepam, this strongly supports a diagnosis of catatonia. This test serves both as a diagnostic tool and the beginning of treatment, as benzodiazepines are a primary treatment for catatonia.^[7][10]

The lorazepam challenge is particularly helpful in cases where the diagnosis is uncertain. However, improvement with lorazepam is not absolutely specific to catatonia, as some other conditions may also show temporary improvement. Therefore, doctors interpret the results of this challenge test alongside the complete clinical picture, including the person’s symptoms, medical history, and results of other examinations.^[13]

Medical History Review

A thorough review of the person’s medical and psychiatric history is essential for diagnosis. The doctor will inquire about previous episodes of similar symptoms, any psychiatric diagnoses such as bipolar disorder or depression, recent infections or illnesses, head injuries, exposure to medications (especially antipsychotics), and substance use. This information helps identify potential causes of catatonia and guides treatment decisions.^[6]

Family history may also provide important clues. Some people experience repeated episodes of catatonia, and in rare cases, there may be a genetic component. Understanding the pattern of previous episodes can help doctors anticipate the course of the current episode and plan appropriate follow-up care.^[7]

Additional Diagnostic Tests

While catatonia is diagnosed primarily through clinical examination, doctors often order additional tests to identify underlying causes or rule out other conditions. These may include blood tests to check for infections, metabolic abnormalities, thyroid problems, or drug toxicity. Neuroimaging studies such as brain CT or MRI scans may be performed to look for structural brain abnormalities, strokes, tumors, or signs of inflammation. An electroencephalogram (EEG), which measures brain electrical activity, may be done to rule out seizures.^[6]

These tests don’t diagnose catatonia itself but help identify what might be causing it. Catatonia can result from many different underlying conditions including infections, autoimmune diseases, medication side effects, metabolic disturbances, or psychiatric illnesses. Identifying and treating the underlying cause is an important part of managing catatonia.^[5]

Diagnostics for Clinical Trial Qualification

When patients with catatonia are being considered for participation in clinical trials, they typically undergo more rigorous and standardized diagnostic assessments. Clinical trials require precise documentation of symptoms and severity to ensure that participants truly have the condition being studied and to measure whether experimental treatments are working.

Standardized Assessment Tools in Research Settings

Clinical trials for catatonia commonly use validated rating scales to confirm diagnosis and track treatment response. The Bush-Francis Catatonia Rating Scale, mentioned earlier, consists of two parts: a screening instrument with 14 items and a severity scale with 23 items. Research protocols typically require specific cutoff scores on these scales for trial enrollment, ensuring that participants have catatonia of sufficient severity to detect treatment effects.^[10]

Another tool sometimes used in research is the Northoff Catatonia Scale, which assesses both motor symptoms and the subjective experience of patients with catatonia. This scale recognizes that catatonia involves not just observable motor abnormalities but also intense internal emotional and cognitive experiences that patients describe once they recover enough to communicate.^[8]

Baseline Medical Evaluations

Before enrolling in a clinical trial, participants undergo comprehensive baseline medical evaluations. These typically include detailed psychiatric and medical histories, complete physical examinations, vital signs monitoring (blood pressure, heart rate, temperature, breathing rate), and laboratory tests including complete blood count, comprehensive metabolic panel, thyroid function tests, and sometimes drug screening. These baseline assessments help ensure patient safety and provide comparison points for monitoring changes during the trial.^[6]

Documentation of Previous Treatments

Clinical trial protocols often require documentation of how participants have responded to previous treatments for catatonia. This might include records showing whether they improved with benzodiazepines like lorazepam, whether they have undergone electroconvulsive therapy (ECT), and what medications they have tried. Some trials specifically recruit patients who haven’t responded to standard treatments, while others may focus on first-episode cases. This treatment history helps researchers understand which patients might benefit most from new therapies being tested.^[10]

Exclusion Criteria and Safety Screening

Clinical trials have specific criteria that determine who cannot participate, called exclusion criteria. For catatonia studies, common exclusions might include certain severe medical conditions, pregnancy, recent substance abuse, or the presence of conditions that could be confused with catatonia. Safety screening ensures that experimental treatments won’t pose unacceptable risks to participants. This might involve checking liver and kidney function, performing electrocardiograms to assess heart rhythm, and screening for conditions that might increase risks from the treatment being studied.^[12]

Ongoing Monitoring During Trials

Once enrolled in a clinical trial, participants undergo frequent reassessments using the same standardized tools. This allows researchers to track symptom changes objectively and determine whether the experimental treatment is effective. Monitoring typically includes repeated administration of catatonia rating scales, vital signs checks, blood tests to monitor for side effects, and regular neurological examinations. This intensive monitoring helps ensure participant safety while generating the data needed to evaluate new treatments.^[10]

The rigorous diagnostic and monitoring procedures in clinical trials differ from routine clinical care because research requires more documentation, standardization, and frequent assessment. However, the same basic principles apply: careful observation, use of validated assessment tools, consideration of alternative diagnoses, and attention to both the symptoms of catatonia and any underlying conditions that might be causing it.